| Primary |
| Nasal Congestion |
32.6% |
| Nasopharyngitis |
11.1% |
| Dyspnoea |
5.9% |
| Influenza Like Illness |
5.9% |
| Intentional Overdose |
5.2% |
| Maternal Exposure During Pregnancy |
5.2% |
| Retinopathy Of Prematurity |
4.4% |
| Sinus Congestion |
3.7% |
| Hypersensitivity |
3.0% |
| Seasonal Allergy |
3.0% |
| Accidental Exposure |
2.2% |
| Anaesthesia |
2.2% |
| Dry Eye |
2.2% |
| Local Anaesthesia |
2.2% |
| Mydriasis |
2.2% |
| Postoperative Analgesia |
2.2% |
| Sinusitis |
2.2% |
| Anxiety |
1.5% |
| Blood Cholesterol Increased |
1.5% |
| Contraception |
1.5% |
|
| Drug Dependence |
22.5% |
| Incorrect Drug Administration Duration |
22.5% |
| Off Label Use |
7.0% |
| Maternal Exposure During Pregnancy |
5.6% |
| Dyspnoea |
4.2% |
| Hypertension |
4.2% |
| Underdose |
4.2% |
| Heart Rate Increased |
2.8% |
| Necrotising Colitis |
2.8% |
| Overdose |
2.8% |
| Palpitations |
2.8% |
| Placental Disorder |
2.8% |
| Pulmonary Oedema |
2.8% |
| Transient Ischaemic Attack |
2.8% |
| Urticaria |
2.8% |
| Accidental Exposure |
1.4% |
| Amyotrophic Lateral Sclerosis |
1.4% |
| Anaphylactic Reaction |
1.4% |
| Asthma |
1.4% |
| Blood Cholesterol Increased |
1.4% |
|
| Secondary |
| Preoperative Care |
22.9% |
| Product Used For Unknown Indication |
19.5% |
| Anaesthesia |
9.2% |
| Intentional Overdose |
8.9% |
| Antibiotic Prophylaxis |
5.9% |
| General Anaesthesia |
5.5% |
| Cataract Operation |
3.7% |
| Drug Exposure During Pregnancy |
3.4% |
| Nasal Congestion |
3.4% |
| Nasopharyngitis |
3.0% |
| Vascular Operation |
2.1% |
| Influenza Like Illness |
1.8% |
| Sinus Congestion |
1.8% |
| Depression |
1.4% |
| Haemodynamic Instability |
1.4% |
| Hypotension |
1.4% |
| Sinus Headache |
1.4% |
| Intraocular Lens Implant |
1.1% |
| Mean Arterial Pressure |
1.1% |
| Mydriasis |
1.1% |
|
| Endophthalmitis |
30.9% |
| Priapism |
7.4% |
| Inflammation |
6.2% |
| Incorrect Drug Administration Duration |
4.9% |
| Rhabdomyolysis |
4.9% |
| Bronchitis |
3.7% |
| Drug Dependence |
3.7% |
| Hypertension |
3.7% |
| Maternal Exposure During Pregnancy |
3.7% |
| Mouth Breathing |
3.7% |
| Rash Erythematous |
3.7% |
| Toxic Anterior Segment Syndrome |
3.7% |
| Cardio-respiratory Arrest |
2.5% |
| Heart Rate Increased |
2.5% |
| Miosis |
2.5% |
| Myalgia |
2.5% |
| Off Label Use |
2.5% |
| Placental Disorder |
2.5% |
| Product Label Issue |
2.5% |
| Tendonitis |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
72.9% |
| Coronary Artery Bypass |
8.2% |
| Aortic Valve Replacement |
2.5% |
| Catheterisation Cardiac |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Mitral Valve Replacement |
1.3% |
| Hypertension |
1.2% |
| Mitral Valve Repair |
1.1% |
| Pain |
0.9% |
| Cardiac Operation |
0.8% |
| Intraocular Lens Implant |
0.8% |
| Hypotension |
0.7% |
| Anaesthesia |
0.6% |
| Aortic Surgery |
0.6% |
| Blood Pressure Management |
0.6% |
| Multiple Myeloma |
0.6% |
| Diabetes Mellitus |
0.6% |
| Maintenance Of Anaesthesia |
0.6% |
| Aortic Aneurysm Repair |
0.5% |
| Atrial Fibrillation |
0.5% |
|
| Pain |
13.8% |
| Injury |
12.3% |
| Unevaluable Event |
10.3% |
| Anxiety |
9.1% |
| Renal Failure |
7.9% |
| Fear |
7.6% |
| Anhedonia |
5.9% |
| Depression |
5.0% |
| Emotional Distress |
5.0% |
| Renal Injury |
4.7% |
| Stress |
3.5% |
| Renal Impairment |
2.6% |
| Renal Failure Acute |
2.3% |
| Blood Pressure Decreased |
1.8% |
| Death |
1.8% |
| Multi-organ Failure |
1.5% |
| White Blood Cell Count Increased |
1.5% |
| Cerebral Infarction |
1.2% |
| Floppy Iris Syndrome |
1.2% |
| Psychiatric Symptom |
1.2% |
|
| Interacting |
| Hypotension |
25.0% |
| Anxiety |
12.5% |
| Bronchospasm |
12.5% |
| Leukocoria |
12.5% |
| Ocular Vasculitis |
12.5% |
| Retinoblastoma |
12.5% |
| Thrombosis |
12.5% |
|
| Drug Interaction |
50.0% |
| Neurotoxicity |
50.0% |
|
